Commenters Disagree on Waiver for Lung Fluid Measurement Device
The GPS Innovation Alliance opposed an FCC waiver sought by Sensible Medical Innovations (SMI) for a system that uses ultra-wideband medical imaging to obtain lung fluid measurements for congestive heart failure patients in a noninvasive way (see 1802090040). Initial comments…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
were due in docket 18-39 Monday. SMI hasn’t offered “sufficient technical information to justify” the waiver grant, said the GPS group. “The Commission takes a conservative approach applying these waiver standards to petitioners seeking to operate equipment co-channel with incumbent operations, placing a heavy burden on the petitioner to demonstrate how it will provide adequate protection from interference,” the alliance said. “When the petitioner does not adequately demonstrate how it will avoid creating interference, the Commission has not acted favorably.” The National Public Safety Telecommunications Council urged approval. “NPSTC is guided primarily by its view that a noninvasive medical system to measure lung fluid in congestive heart failure patients provides positive benefits to patients, and potentially to emergency medical service (EMS) personnel that may need to serve these patients,” NPSTC said.